Whitehawk Therapeutics (WHWK) Notes Payables (2010 - 2020)
Whitehawk Therapeutics (WHWK) posted quarterly Notes Payables of $9.0 million for Q4 2020, down 27.11% quarter-over-quarter from $12.4 million in Q4 2016.
Whitehawk Therapeutics (WHWK) Notes Payables (2010 - 2020) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Notes Payables for 8 consecutive years, with $9.0 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Notes Payables changed N/A year-over-year to $9.0 million; the TTM figure through Dec 2020 stood at $9.0 million (changed N/A YoY), while the FY2020 annual figure was $9.0 million, changed N/A from the prior year.
- Notes Payables retreated to $9.0 million in Q4 2020 per WHWK's latest filing, from $12.4 million in the prior quarter.
- Across five years, Notes Payables topped out at $12.4 million in Q4 2016 and bottomed at $160000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 9.03 Mn |
| Dec 31, 2016 | 12.39 Mn |
| Sep 30, 2016 | 170,000.00 |
| Jun 30, 2016 | 170,000.00 |
| Mar 31, 2016 | 160,000.00 |
| Dec 31, 2015 | 160,000.00 |
| Sep 30, 2015 | 145,000.00 |
| Jun 30, 2015 | 145,000.00 |
| Mar 31, 2015 | 145,000.00 |
| Dec 31, 2014 | 125,000.00 |
| Sep 30, 2014 | 125,000.00 |
| Jun 30, 2014 | 110,000.00 |
| Mar 31, 2014 | 110,000.00 |
| Dec 31, 2013 | 110,000.00 |
| Sep 30, 2013 | 110,000.00 |
| Jun 30, 2013 | 110,000.00 |
| Mar 31, 2013 | 85,000.00 |
| Dec 31, 2012 | 85,000.00 |
| Sep 30, 2012 | 85,000.00 |
| Jun 30, 2012 | 85,000.00 |